✦ LIBER ✦

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

✍ Scribed by Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (author);Kamaruddin, N. A. (author);Strand, J. (author);Zdravkovic, M. (author);Le Thi, T. D. (author);Colagiuri, S. (author)

Book ID: 110926630
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 803 KB
Volume: 26
Category: Article
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2009.02666.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide, a once-daily human GLP-1 an

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

✍ Marre, M. (author);Shaw, J. (author);Brändle, M. (author);Bebakar, W. M.W. (auth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

Liraglutide, a Once-daily Human GLP-1 An

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycemic Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Duri 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 681 KB

Liraglutide, a Once-daily Human GLP-1 An

Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycem1c Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin.

✍ Frid, A.; Nauck, M.A.; Hermansen, K.; Shah, N.S.; Tankova, T.; Mitha, I.H.; Duri 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 681 KB

Liraglutide, a once-daily human glucagon

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Weight loss with liraglutide, a once-dai

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

✍ J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB